• Richard Branson and the tale of the missing receipt (The Globe and Mail), http://ow.ly/4ivdi #
  • Former Enforcer Sees Looming Fights: Is the tide turning against corruption? (WSJ) http://ow.ly/4ivl4 #
  • Entrepreneurship: A Look at the Nature-Nurture Debate (In Charge – WSJ), http://ow.ly/4ivr8 #
  • Not just for drinking: 7 Alternative Uses for Beer (mental_floss Blog), http://ow.ly/4ivxr #
  • The business card still holds its own (The Globe and Mail), http://ow.ly/4iwSf #
  • New Order is no more. Faithless is no more. Music out there is still good, but still hurts when good groups are no more. #
  • Patent reform: The spluttering invention machine (The Economist), http://ow.ly/4hY53 #
  • Astellas to buy out Maxygen interest in joint venture for $76M (San Francisco Business Times), http://ow.ly/4ivfm #
  • Stem cells from bone marrow hold promise for heart enlargement (US News and World Report), http://ow.ly/4ivgb #
  • DNA test is designed to monitor health effects of stress (WSJ), http://ow.ly/4ivgI #
  • Boom Times for Genomics Startups: Gene sequencers benefit drugmakers, agricultural firms (BusinessWeek), http://ow.ly/4ivhI #
  • Genfit-Sanofi deal will focus on drugs for metabolic disorders (Reuters), http://ow.ly/4iviz #
  • Pfizer examines which units would do better "outside the company" (Reuters), http://ow.ly/4ivjb #
  • EU wrestles with issue of food from cloned animals (Reuters), http://ow.ly/4ivjR #

Comments are closed.